We are a multi-disciplinary team of scientists, biologists, clinicians, AI engineers and innovators.
Led by globally recognised scientists in the field of age-related disease with more than 1000 scientific publications and an AI team with more than 30 global AI awards.
Based on our proprietary award-winning AI solutions, Aladdin has developed 3 core platforms: Drug Discovery, Biomedical Knowledge Graphs and Disease Diagnosis.
These platforms will enable superior acceleration of the drug discovery process and deliver more accurate and cost-effective age-related disease diagnosis.
Unter den Linden 10, 10117 Berlin – Germany
|Date||Trading entity / Person||Association||Trade type||Volume|
|02.02.22||Menpes-Smith, Mr Wade||Board||Other||211,425.00 €|
|21.09.21||Continental Aktiengesellschaft||Close relation||Sell||243,288.00 €|
|20.09.21||Smith, Wade||Board||Other||211,425.00 €|
May 22, 2020Stock exchange(s)
Berlin Stock Exchange, Düsseldorf Stock Exchange, Frankfurt Stock Exchange, Munich Stock Exchange